Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
107.91B
Market cap107.91B
Price-Earnings ratio
25.58
Price-Earnings ratio25.58
Dividend yield
3.33%
Dividend yield3.33%
Average volume
6.13M
Average volume6.13M
High today
$84.78
High today$84.78
Low today
$83.50
Low today$83.50
Open price
$84.39
Open price$84.39
Volume
5.88M
Volume5.88M
52 Week high
$96.25
52 Week high$96.25
52 Week low
$75.96
52 Week low$75.96

MDT News

TipRanks 12h
Medtronic announces Expand URO IDE study met primary safety, effective endpoint

Medtronic (MDT) announced that the Expand URO Investigational Device Exemption , IDE, clinical study, the largest such study for robotic-assisted urologic surge...

TipRanks 12h
Medtronic announces outcomes from two studies in AFib patients

Medtronic (MDT) announced positive clinical outcomes from two studies in atrial fibrillation, AFib, patients treated with the Affera family of technologies, inc...

Seeking Alpha 2d
Medtronic seeks FDA nod for Hugo robotic surgery system

Medtronic (NYSE:MDT) confirmed on Saturday the submission of regulatory filings with the FDA to obtain marketing approval for its Hugo robotic-assisted surgery...

Medtronic seeks FDA nod for Hugo robotic surgery system

Analyst ratings

47%

of 32 ratings
Buy
46.9%
Hold
43.8%
Sell
9.4%

More MDT News

Simply Wall St 2d
Medtronic Secures FDA Approval For Innovative OmniaSecure Defibrillation Lead

recently announced FDA approval of its OmniaSecure™ defibrillation lead, marking a key advancement in cardiovascular technology, along with results from its LEA...

Medtronic Secures FDA Approval For Innovative OmniaSecure Defibrillation Lead
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.